New quinoline di-mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine?

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1369-1374

  Kotecka, Barbara M ^a   Barlin, Gordon B ^b   Edstein, Michael D ^a   Rieckmann, Karl H ^a  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; GBB 1606; PYRONARIDINE; QUINOLINE DERIVATIVE; TN 109; TN 112; TN 121; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MONKEY; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030969247     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1369     Document Type: Article

References (38)

1. Alin, M. H., A. Bjorkman, and M. Ashton. 1492. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 84:635-637.
2. Barlin, G. B., and S. J. Ireland. 1988. Potential antimalarials. VII. Di-Mannich bases of 4-[(7′-trifluoromethylquinolin-4′-yl)- and 4-(7′-bromo -1′,5′-naphthyridin-4′-yl)]aminophenol via 4-nitrophenols. Aust. J. Chem. 41:1727-1733.
3. Barlin, G. B., S. J. Ireland, T. M. T. Nguyen, B. Kotecka, and K. H. Rieckmann. 1994. Potential antimalarials. XXI. Mannich hase derivatives of 4-[7-chloro (and 7-trifluoromethyl)quinolin-4-ylamino]phenols. Aust. J. Chem. 47:1553-1560.
4. Barlin, G. B., C. Jiravinyu, G. B. Butcher, B. Kotecka, and K. H. Rieckmann. 1992. The in vitro and in vivo antimalarial activity of some Mannich bases derived from 4-(7′trifluoromethyl-1′,5′-naphthyridin-4′-ylamino) phenol, 2-(7-trifluoromethylquinolin-4′-ylamino)phenol, and 4′-chloro-5-(7′-trifluoromethylquinolin-4′-ylamino)biphenyl-2- ols. Ann. Trop. Med. Parasitol. 86:323-331.
5. Barlin, G. B., and C. Jiravinyu. 1991. Potential antimalarials. XIII. Mono-Mannich bases of 4-[7-chloro (and 7-trifluoromethyl) quinolin-4-ylamino]- and 4-[7-bromo-1,5-naphthyridin-4-ylamino]-3-methylphenol. Aust. J. Chem. 41: 151-156.
6. Barlin, G. B., T. M. T. Nguyen, B. Kotecka, and K. H. Rieckmann. 1992. Potential antimalarials. XV. Di-Mannich bases of 2-(7′-chloroquinolin-4′-ylamino)phenol and 2-[7′-bromo(and trifluoromethyl)-1′,5′-naphthyridin-4′-ylamino]phenol. Aust. J. Chem. 45:1651-1662.
7. Barlin, G. B., and W.-L. Tan. 1985. Potential antimalarials. V. 4-(7′-Trifluoromethylquinolin-4′-ylamino)phenols, 4-[2′,7′- and 2′,8′-bis-(trifluoromethyl) quinolin4′-ylamino]phenols and N′-substituted 2,7- (and 2,8)-bis(trifluoromethyl)quinolin-4-amines. Aust. J. Chem. 38:1827-1835.
8. Barlin, G. B., and W.-L. Tan. 1986. Potential antimalarials. VI. Mannich bases derived from 4-[7′-bromo (and chloro)-1′5′-naphthyridin-4′-ylamino]phenols and 4-(7′-trifluoromethylquinolin-4′-ylamino)phenol. Aust. J. Chem. 39:51-57.
9. Barlin, G. B., and H. Yan. 1989. Potential antimalarials. VIII. Mono- and di-Mannich bases of 2-(7′-trifluoromethylquinolin-4′-ylamino)phenol via 2-nitrophenols. Aust. J. Chem. 42:2191-2199.
10. Brasco, L. K., and J. Le Bras. 1992. In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Ann. Trop. Med. Parasitol. 86: 447-454.
11. Bygberg, I. C., A. Schapira, H. Flachs, G. Gomme, and S. Jepsen. 1983. Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment. Lancet i:774-775.
12. Chang, C., T. Lin-Hu, and C. Jantanavivat. 1992. Studies on a new antimalarial compound: pyronaridine. Trans. R. Soc. Trop. Med. Hyg. 86:7-10.
13. Chen, P., G. Lamont, T. Elliott, C. Kidson, G. Brown, G. Mitchell, J. Stace, and M. Alpers. 1980. Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. Southeast Asian J. Trop. Med. Public Health 11:435-440.
14. Childs, G. E., B. Hausler, W. Milhous, C. Chen, T. Wimonwattrawatee, N. Pooyindee, and E. F. Boudreau. 1988. In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 38:24-29.
15. Churchill, F. C., L. C. Patchen, C. C. Campbell, I. K. Schwartz, P. K. Nguyen-Dinh, and C. M. Dickson. 1985. Amodiaquine as a pro-drug: importance of metabolites in the antimalarial effect of chloroquine in humans. Life Sci. 36:53-62.
16. Desjardins, R. E., C. J. Canfield, D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
17. Fu, S., and S. X. Xiao. 1991. Pyronaridine: a new antimalarial drug. Parasitology Today 7:310-313.
18. Gibaldi, M. 1991. Biopharmaceutics and clinical pharmacokinetics, 4th ed. Lea and Febiger, Philadelphia. Pa.
19. Harrison, A. C., N. R. Kitteringham, J. B. Clarke, and B. K. Park. 1992. The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochem. Pharmacol. 43:1421-1430.
20. Hatton, C. S. R., C. Bunch, T. E. A. Peto, G. Pasvol, S. J. Russell, C. R. J. Singer, G. Edwards, and P. Winstanley. 1986. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet i:411-414.
21. Institute of Parasitic Diseases, Chinese Academy of Medical Sciences. 1980. Experimental studies on chemotherapeutic effects and toxicities of a new antimalarial drug 7351. Acta Pharm. Sinica 15:630-632.
22. Kotecka, B. K., and K. H. Rieckmann. 1993. Chloroquine bioassay using malaria microcultures. Am. J. Trop. Med. Hyg. 49:460-464.
23. Kotecka, B. M., and K. H. Rieckmann. 1995. In vivo-in vitro model to assess chloroquine activity in monkeys. Chemotherapy 44:134-140.
24. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
25. Looareesuwan, S., D. E. Kyle, C. Viravan, S. Vanijanonta, P. Wilairatana, and W. H. Wernsdorfer. 1996. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 54:205-209.
26. Looareesuwan, S., C. Viravan, H. K. Webster, D. E. Kyle, D. B. Hutchinson, and C. J. Canfield. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54:62-66.
27. Muller, O., M. Boele van Hensbroek, S. Jaffar, C. Drakeley, C. Okorie, D. Joof, M. Pinder, and B. Greenwood. 1996. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop. Med. Int. Health 1:124-132.
28. Neftel, K. A., W. Woodtly, M. Schmid, P. G. Frick, and J. Fehr. 1986. Amodiaquine induced agranulocytosis and liver damage. Br. Med. J. 292: 721-723.
29. Oduala, A. M. J., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1988. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp. Parasitol. 66:86-95.
30. Rieckmann, K. 1971. Determination of the drug sensitivity of Plasmodium falciparum. JAMA 217:573-578.
31. Ringwald, P., J. Bickii, and L. Basco. 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347:24-28.
32. Scott, H. V., W. L. Tan, and G. B. Barlin. 1987. Antimalarial activity of Mannich bases derived from 4-(7′-bromo-1′,5′-naphthyridin-4′-ylamino) phenol and 4-(7′-trifluoromethylquinolin-4′-ylamino)phenol against Plasmodium falciparum in vitro. Ann. Trop. Med. Parasitol. 81:85-93.
33. Scott, H. V., W. L. Tan, and G. B. Barlin. 1988. The in vitro and in vivo antimalarial activity of some Mannich bases derived from 4-[7′-bromo(and chloro)-1′,5′-naphthyridin-4′-ylamino]phenol and 4-(7′-trifluoromethylquinolin-4′ylamino)phenol. Ann. Trop. Med. Parasitol. 82:127-134.
34. Shanks, G. D., G. Watt, M. D. Edstein, H. K. Webster, V. Suriyamongkol, C. Watanasook, S. Panpunnung, and W. Kowinwiphat. 1991. Halofantrine for the treatment of mefloquine chemoprophylaxis failures. Am. J. Trop. Med. Hyg. 45:488-491.
35. Thaitong, S., and G. H. Beale. 1981. Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Trans. R. Soc. Trop. Med. Hyg. 75:271-273.
36. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
37. Warrell, D. A., M. E. Molyneux, and P. P. Beales. 1990. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84:1-65.
38. Watkins, W. M., H. C. Spencer, D. M. Kariuki, D. G. Sixsmith, D. A. Boriga, T. Kipingor, and D. K. Koech. 1984. Effectiveness of amodiaquine as treatment for chloroquine-resistant Piasmodium falciparum infections in Kenya. Lancet i:357-359.